Premium
Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive‐ and impulsive‐like behaviors and on monoamine transmission in experimental temporal lobe epilepsy
Author(s) -
Kumar Udaya,
MedelMatus JesusServando,
Redwine Hannah M.,
Shin Don,
Hensler Julie G.,
Sankar Raman,
Mazarati Andrey
Publication year - 2016
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/epi.13321
Subject(s) - serotonergic , serotonin , monoamine neurotransmitter , norepinephrine , medicine , endocrinology , serotonin reuptake inhibitor , locus coeruleus , antidepressant , reuptake inhibitor , psychology , behavioural despair test , chemistry , neuroscience , receptor , dopamine , central nervous system , hippocampus
Summary Objective Examine therapeutic potential of a selective serotonin reuptake inhibitor ( SSRI ) and a norepinephrine reuptake inhibitor ( NERI ) in an animal model of comorbidity between epilepsy, depression‐like, and impulsive‐like impairments. Methods Epilepsy was induced in male Wistar rats by LiCl and pilocarpine. An SSRI fluoxetine ( FLX ), and an NERI reboxetine ( RBX ) were administered either alone or as a combination over 1 week. Depressive‐like and impulsive‐like behaviors were examined using the forced swim test. Fast scan cyclic voltammetry was used to analyze serotonergic transmission in the raphe nucleus ( RN )–prefrontal cortex ( PFC ) pathway, and noradrenergic transmission in locus coeruleus ( LC )‐ PFC , and LC ‐ RN projections. Monoamine levels in PFC were measured using high‐performance liquid chromatography (HPLC). Functional capacities of 5‐ HT 1A receptors and α2A adrenoreceptors in PFC were analyzed by autoradiography. Results Epileptic rats showed behavioral signs of depression and hyperimpulsivity, suppressed serotonergic and noradrenergic tones, decreased levels of serotonin (5‐ HT ), and norepinephrine ( NE ); 5‐ HT 1A receptor and α2A adrenoreceptors functions remained intact. FLX failed to improve behavioral deficits, but effectively raised 5‐ HT level and marginally improved RN ‐ PFC serotonergic transmission. RBX reversed impulsive‐like behavior, normalized content of NE and noradrenergic tone in LC ‐ PFC and LC ‐ RN . FLX ‐ RBX combination fully reversed depressive‐like behavior, and normalized RN ‐ PFC serotonergic transmission. None of the treatment modified the function of 5‐ HT and NE receptors. Significance Depressive‐ and impulsive‐like behaviors in the pilocarpine model of epilepsy stem respectively from dysfunctions of serotonergic and noradrenergic ascending pathways. At the same time, epilepsy‐associated depression is SSRI resistant. The finding that an SSRI ‐ NERI combination exerts antidepressant effect, along with RBX ‐induced improvement of LC ‐ RN noradrenergic transmission point toward the involvement of LC ‐ RN noradrenergic input in enabling therapeutic potential of FLX . Medications that improve serotonergic and noradrenergic transmission, such as serotonin–norepinephrine reuptake inhibitors may be effective in treating epilepsy‐associated SSRI ‐resistant depression, as well as concurrent depression and attention‐deficit/hyperactivity disorder ( ADHD ).